Table 2:
Correlation of high-risk human papillomavirus test results with biopsies in atrophic cellular pattern and without atrophic cellular pattern group.
| hrHPVT result | Biopsy positive for HGD | Biopsy negative for HGD | PPV (%) | NPV (%) |
|---|---|---|---|---|
| ACP group (total 48*) | ||||
| HPV+ (T: 21) | 14 | 7 | 67 | |
| HPV− (T: 27) | 7 | 20 | 74 | |
| Sensitivity (%) | 67 | |||
| Specificity (%) | 74 | |||
| Non-ACP group (total 59**) | ||||
| HPV+ (T: 48) | 41 | 7 | 85 | |
| HPV− (T: 11) | 5 | 6 | 55 | |
| Sensitivity (%) | 89 | |||
| Specificity (%) | 46 | |||
*
Of 67 cases in ACP group, hrHPVT results were available in 48 cases, **Of 67 cases in non-ACP group, hrHPVT results were available in 59 cases. +: Positive, −: Negative, ACP: Atrophic cellular pattern, Non-ACP: Without ACP, HPV: Human papillomavirus, hrHPVT: High-risk HPV test, CIN2: Cervical intraepithelial neoplasm 2, HGD: Higher than CIN2 dysplasia, PPV: Positive predictive value, NPV: Negative predictive value